| 中文名称 |
Punicalagin
|
|---|---|
| 中文别名 |
安石榴苷;安石榴甙;安石榴甙(安石榴苷);安石榴苷(安石榴甙);安石榴苷,Punicalagin,植物提取物,标准品,对照品;安石榴苷、安石榴甙;安石榴苷Punicalagin;安石榴苷对照品;石榴皮提取物
|
| 英文名称 |
Punicalagin
|
| 英文别名 |
Punicalagin;Punicalagins;PUNICALAGINS A&B(P);B(P);PULCHINENOSIDE B4(RG);PUNICALAGINS A&D-Glucose,cyclic4,6-[2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]]cyclic 2,3-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate),[2(S),4(S,S)]-;2,20,1,23-(Epoxy[2]propene[1,2]diyl[3]ylidene)-11H,15H-tribenzo[g,i,q][1,5,12]trioxacyclononadecin,D-glucose deriv.;Dibenzo[f,h][1,4]dioxecin, D-glucose deriv.;D-Glucose,cyclic 4,6-[(S,S)-2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]]cyclic 2,3-[(S)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate];D-Glucose, cyclic4,6-[(2S,2'S)-2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]]cyclic 2,3-[(S)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate];BDBM50377922;N1687;(1R,35R,37R,38R,55S)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-Heptadecahydroxy-2,14,21,33,36,;(1R,35R,37R,38R,55S)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-heptadecahydroxy-2,14,21,33,36,
|
| Cas No. |
65995-63-3
|
| 分子式 |
C48H28O30
|
| 分子量 |
1084.72
|
| 包装储存 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| 详情描述 |
Punicalagin是一种从石榴(Punica granatum L.)或Terminalia catappa L.的叶子中分离的多酚成分。Punicalagin是一种抗乙型肝炎病毒(HBV)药物,具有抗氧化,抗炎和抗癌作用。 |
| 生物活性 |
Punicalagin is a polyphenol ingredient isolated from Pomegranate (Punica granatum L.) or the leaves of Terminalia catappa L.. Punicalagin is a reversible and non-competitive 3CL inhibitor and inhibits SARS-CoV-2 replication 体外研究. Punicalagin is an anti-hepatitis B virus (HBV) agent and has antioxidant, anti-inflammatory, and anticancer effects. Punicalagin has the potential for the research of COVID-19. |
|---|---|
| 性状 |
Solid |
| 体外研究(In Vitro) |
Punicalagin (100 mg/ml) induces apoptosis in HT-29, HCT116 colon cells. Medlife has not independently confirmed the accuracy of these methods. They are for reference only. |
| 体内研究(In Vivo) |
Punicalagin (10 mg/kg) inhibits the edema rate of 58.15% in rats. Medlife has not independently confirmed the accuracy of these methods. They are for reference only. |
| 运输条件 |
Room temperature or refrigerated transportation. |
| 储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| ClinicalTrial |
|
| 结构分类 | |
| 来源 | |
| 参考文献 |
|
| 溶解度数据 |
体外研究:
DMSO : 50 mg/mL (46.09 mM; Need ultrasonic) 配制储备溶液
*
产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效。 体内研究:
建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*
|
|---|
[1]. Seeram NP, et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagicacid and a total pomegranate tannin extract are enhanced in combination with otherpolyphenols as found in pomegranate juice. J Nutr Biochem. 2005 Jun [Information]
[2]. Lin CC, et al. Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats. Am J Chin Med. 1999;27(3-4):371-6. [Information]
[3]. Liu C, et al. Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA. Antiviral Res. 2016 Oct;134:97-107. [Information]
[4]. RuikunDu, et al. Discovery of Chebulagic Acid and Punicalagin as Novel Allosteric Inhibitors of SARS-CoV-2 3CLpro. Antivir Res. 2021, 105075. [Information]
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。
Copyright © 2025 陌孚医药 All rights reserved 未经授权禁止拷贝本站所有资料,如有违反,将追究法律责任。
沪ICP备2023012080号 |
沪公网安备31011402010657号
扫码关注公众号